Table 3.
Associations between disease history and prescription of moderated-intensity or high-intensity statins
2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |
History of hypertension | 1.04 | 1.16 | 1.04 | 0.92 | 1.01 | 0.98 | 1.09 | 1.04 | 1.02 | 1.05 | 1.20 |
0.94–1.15 | 1.03–1.29 | 0.92–1.18 | 0.80–1.07 | 0.87–1.18 | 0.84–1.14 | 0.94–1.26 | 0.90–1.20 | 0.87–1.19 | 0.88–1.24 | 1.00–1.44 | |
History of diabetes | 1.12 | 1.15 | 0.99 | 0.94 | 0.75 | 0.82 | 0.78 | 0.78 | 0.92 | 0.83 | 0.92 |
1.01–1.24 | 1.03–1.29 | 0.88–1.12 | 0.81–1.09 | 0.64–0.87 | 0.70–0.96 | 0.68–0.91 | 0.67–0.91 | 0.78–1.08 | 0.69–0.99 | 0.76–1.11 | |
History of DoA | 1.00 | 0.99 | 1.01 | 1.01 | 1.02 | 1.08 | 0.98 | 1.08 | 1.10 | 1.02 | 1.03 |
0.87–1.15 | 0.86–1.14 | 0.87–1.18 | 0.85–1.20 | 0.85–1.21 | 0.91–1.30 | 0.83–1.17 | 0.91–1.31 | 0.91–1.34 | 0.82–1.25 | 0.82–1.30 | |
History of CeVD | 1.18 | 1.20 | 0.84 | 0.83 | 0.69 | 0.88 | 0.70 | 0.85 | 0.80 | 0.72 | 0.77 |
1.00–1.38 | 1.01–1.42 | 0.71–0.99 | 0.69–1.01 | 0.57–0.83 | 0.71–1.08 | 0.58–0.84 | 0.70–1.04 | 0.65–0.98 | 0.58–0.90 | 0.60–0.98 | |
History of IHD |
1.41 | 1.26 | 1.04 | 1.02 | 0.76 | 0.75 | 0.94 | 0.88 | 1.01 | 1.06 | 0.92 |
1.24–1.60 | 1.09–1.44 | 0.90–1.21 | 0.85–1.22 | 0.64–0.91 | 0.63–0.90 | 0.78–1.13 | 0.73–1.06 | 0.82–1.23 | 0.85–1.33 | 0.72–1.18 |
CeVD, cerebrovascular diseases; DoA, diseases of arteries, arterioles and capillaries; IHD, ischaemic heart disease.